Batten Disease Clinical Research Consortium (BDCRC)
Grant number: U54 HD122210-01
Principal Investigator: Erika Augustine, MD, MS
Lead Institution: Kennedy Krieger Institute
Diseases Studied
Neuronal ceroid lipofuscinoses (NCLs, Batten diseases): CLN1, CLN2, CLN3, CLN4, CLN5, CLN6, CLN7, CLN8, CLN10, CLN11, CLN12, CLN13, CLN14
- Neuronal ceroid lipofuscinosis 1, also known as CLN1
- Neuronal ceroid lipofuscinosis 2, also known as CLN2
- Neuronal ceroid lipofuscinosis 3, also known as CLN3
- Ceroid lipofuscinosis, neuronal, 4 (kufs type), also known as CLN4
- Neuronal ceroid lipofuscinosis 5, also known as CLN5
- Ceroid lipofuscinosis, neuronal, 6a, also known as CLN6
- Neuronal ceroid lipofuscinosis 7, also known as CLN7
- Neuronal ceroid lipofuscinosis 8 northern epilepsy variant, also known as CLN8
- Neuronal ceroid lipofuscinosis 10, also known as CLN10
- CLN11
- Parkinsonism due to ATP13A2 deficiency, aslo known as CLN12
- CLN13
- CLN14
Funding Statement
The Batten Disease Clinical Research Consortium (BDCRC) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). BDCRC is funded under grant number U54HD122210 as a collaboration between NCATS, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute of Neurological Disorders and Stroke (NINDS). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818.